News

The global protein purification resin market share analysis is poised for transformative growth between 2025 and 2035, driven ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
The growth of the recombinant proteins market is driven by advancements in biopharmaceutical research, increasing demand for personalized medicin ...
Loopworm, a Bengaluru-based biomanufacturing company developing insect-derived proteins, has raised $3.25 million Pre-Series ...
Loopworm, a biomanufacturing company developing insect-derived proteins, has raised $3.25 million in a pre-Series A funding ...
Ensuring the safety and quality of pharmaceuticals, such as blood products, vaccines, recombinant proteins, and monoclonal antibodies, is essential. Endotoxins act as a hidden ‘time bomb’ in these ...
According to a comprehensive market research report titled "Protein Expression Market by System (Mammalian [CHO, HEK 293], ...
Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...
MVA Vaccine Design for Products Used Against Endemic and Emerging Infectious Diseases ATLANTA, GA - June 25, 2025 ...
The new COVID-19 variant NB.1.8.1, known as Nimbus, is causing concern due to its subtle symptoms and high transmission rate.